The store will not work correctly when cookies are disabled.
Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib
Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib
Copyright © 2025 by STEMCELL Technologies. All rights reserved.